Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

European Commission approves Venclyxto-based combinations for adults with newly diagnosed acute myeloid leukaemia

worldpharmanewsMay 26, 2021

Tag: Venclyxto , AML , Roche , Azacitidine , Decitabine

PharmaSources Customer Service